APP and Alzheimer disease: ACAT inhibitors are being explored pre-clinically for AD, however, while human trials are lacking differential expression of cholesterol ester hydrolases has been observed in AD samples and primary rat cortical neurons transduced with APP (Brown et al., 2004; Hutter-Paier et al., 2004).